Wikidata

(Q61980741)

English

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

clinical trial

In more languages

Statements

title
UARK 2008-02, A Phase II Trial for High-risk Myeloma Evaluation Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-host-exhausting and Timely Dose-reduced MEL-80-VRD-PACE Tandem Transplants (English)
0 references
start time
October 2008
0 references
end time
October 2019
0 references
number of participants
90
0 references
research intervention
cisplatin
0 references
(RS)-cyclophosphamide
0 references
etoposide
0 references
etoposide phosphate
0 references
melphalan
0 references
thalidomide
0 references
bortezomib
0 references
doxorubicin
0 references
Caelyx
0 references
dexamethasone acetate
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980741&oldid=2098423594"